NeoGenomics Completes Acquisition of Genoptix, Inc. December 10, 2018 - 9:00 am NeoGenomics Signs Definitive Agreement to Acquire Genoptix October 23, 2018 - 9:00 am Genoptix Launches FDA-Authorized BCR-ABL MRDx® TFR Monitoring Test for Patients with Chronic Myeloid Leukemia on Tasigna® (nilotinib) September 4, 2018 - 8:30 am This webpage represents 1740240753 NPI record. ICD-10 Codes that Support Medical Necessity ICD-10 CODE DESCRIPTION C88.8 Other malignant immunoproliferative diseases C92.10 Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission C92.20 Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission NPI record contains FOIA-disclosable NPPES health care provider information. NPI record contains FOIA-disclosable NPPES health care provider information. CPT Codes The American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. CPT codes are provided only as guidance to assist clients with billing. ordering option Global (TC & PC) or Tech-only (TC) CONTACT US. Genoptix, a NeoGenomics Company 2131 Faraday Ave Carlsbad, CA 92008 Phone: +1.760.268.6200 Fax: +1.760.268.6201. The 1447437355 NPI number is assigned to the healthcare provider âNEOGENOMICS LABORATORIES INCâ, practice location address at â31 COLUMBIA ALISO VIEJO, CA, 92656â. regulatory classification New York-approved . Background Information for Methylenetetrahydrofolate Reductase (MTHFR), 2 Variants:Characteristics: Variants in the MTHFR gene may reduce enzyme activity contributing to hyperhomocysteinemia. Please review your NPI data to ensure that it is correct and to remove any ⦠Client Services Phone: +1.800.755.1605 NPI record contains FOIA-disclosable NPPES health care provider information. medicare moldx cpt code Not applicable. NPI record contains FOIA-disclosable NPPES health care provider information. The 1154792695 NPI number is assigned to the healthcare provider âNEOGENOMICS LABORATORIES INCâ, practice location address at â2110 RUTHERFORD RD CARLSBAD, CA, 92008-7328â. This webpage represents 1073549663 NPI record. Please review your NPI data to ensure that it is correct and ⦠The 1740240753 NPI number is assigned to the healthcare provider âNEOGENOMICS LABORATORIES INCâ, practice location address at â2110 RUTHERFORD RD CARLSBAD, CA, 92008-7328â. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. Please review your NPI data to ensure that it is correct and to remove any ⦠This webpage represents 1447437355 NPI record. incorporation or organization) ... (FDA approved or LDT), laboratories must apply for and obtain a unique test identifier or what is known as a âZâ code. This webpage represents 1154792695 NPI record. Although hyperhomocysteinemia was previously reported to be a risk factor for many conditions, especially venous thrombosis and cardiovascular disease, recent meta-analysis casts doubt on ⦠Please review your NPI data to ensure that it is correct and to remove any ⦠Genoptix, a NeoGenomics Company 2131 Faraday Ave Carlsbad, CA 92008 Phone: +1.760.268.6200 Fax: +1.760.268.6201. RESULT CODES; Code: Name: Units: Loinc: 92030 : NEOGENOMICS REPORT : 92310 : REASON FOR STUDY : 92315 : CaseID : 92320 : SpecimenID Codes may differ if manual analysis is performed. Enter the appropriate DEX Z-Code⢠identifier adjacent to the CPT® code in the comment/narrative field for the following Part A claim field/types: ⢠⢠Line SV202-7 for 837I electronic claim ⢠Block 80 for the UB04 claim form Coding Information CPT/HCPCS Codes Group 1 Paragraph: N/A Group 1 Codes: CODE DESCRIPTION NEOGENOMICS, INC. (Exact name of registrant as specified in its charter) Nevada : 74-2897368 (State or other jurisdiction of. The 1073549663 NPI number is assigned to the healthcare provider âNEOGENOMICS LABORATORIES INCâ, practice location address at â12701 COMMONWEALTH DR SUITE 9 FORT MYERS, FL, 33913â.